Recent Updates
Recently added Catalysts
ABCL Positive Sentiment

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Friday, January 23, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: AbCellera Biologics Inc. will announce its full year 2025 financial results on February 24, 2026. The announcement will be followed by an earnings conference call at 2:00 p.m. PT. Investors can access a live audio webcast of the call on the company's Investor Relations website, with a replay available afterward.
Price reaction · baseline $4.64 (2026-01-22 close) · hit pre-market · clean, no other ABCL news in the window
day 0 close
-8.6%
day 1
-10.8%
day 3 · peak
-15.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • AbCellera will report its financial results, indicating ongoing operations.
  • The earnings call provides an opportunity for investor engagement.
  • The company is focused on developing antibody-based medicines.

Full Press Release Details

VANCOUVER, British Columbia--(BUSINESS WIRE)--$ABCL--AbCellera (Nasdaq: ABCL) will announce its full year 2025 financial results on Tuesday, February 24, 2026, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
A live audio webcast of the earnings conference may be accessed through a link that will be posted onAbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visitwww.abcellera.com.
InquiriesMedia: Tiffany Chiu;media@abcellera.com, +1(236)521-6774Partnering: Murray McCutcheon, Ph.D.;partnering@abcellera.com, +1(604)559-9005Investor Relations: Peter Ahn;ir@abcellera.com, +1(778)729-9116

Frequently Asked Questions

When will AbCellera report its financial results?

AbCellera will report its full year 2025 financial results on February 24, 2026.

What time is the earnings conference call?

The earnings conference call is scheduled for 2:00 p.m. Pacific Time.

How can I access the earnings call webcast?

The earnings call webcast can be accessed via a link on AbCellera's Investor Relations website.

What is AbCellera focused on developing?

AbCellera is focused on discovering and developing antibody-based medicines.

ShareAdd on Google
Tags: ABCL Viatris Investor Conferences Healthcare AbCellera financial results earnings call biotechnology antibody-based medicines
Last updated: Jan 23, 2026

Biotech snapshot

Cash runway
$540M liquidity · $0M/mo burn
Low dilution risk
Lead asset
ABCL575Phase 1
Healthy Volunteers →